|
Media Releases
|
|
Written by Dr Wilmot James
|
|
Wednesday, 15 April 2009 15:00 |
 Radio astronomy I have learnt the little science I know at the California Institute of Technology (Caltech) when I spent 2003-2004 there as their Moore Visiting Professor in the Humanities. Caltech manages NASA’s Jet Propulsion Laboratory (JPL), the agency responsible for unmanned space flights like the Mars Rovers.
It is also is one of leading science institutions in the world, having produced 25 science laureates (South Africa as a whole has produced 4, to give the figure some perspective). It is on the high end of physics, biology, chemistry, enginee-ring and astronomy.
It is there that I first met the South African astronomer Tony Readhead. Readhead runs an extraordinary observatory in the Andes. He made his expertise available to the South African astronomy community, helping with our bid for the Square Kilometer Array (SQA) for example.
The SQA will be the world’s largest and most sensitive radio telescope. It will consist of thousands of dishes and collecting devices acting as one and covering a square kilometer. The competition is down to Australia and South Africa. The outcome will be announced by 2012. |
|
Read more... [South Africa's efforts to enter radio-astronomy deserves attention]
|
|
Media Releases
|
|
Written by Dr Wilmot James
|
|
Tuesday, 14 April 2009 08:59 |
 Reporting discoveries... The model of science journalism is the New York Times’ Tuesday edition. Four pages of the best science journalism usually accompanied by more topically directed health coverage. Quality is superb, because the journalists have science degrees and know what they are writing about.
There are other newspapers – West European largely – that also take science journalism seriously. Science breakthroughs make great news. Some developments, like the 2008 announcement of the particle physics laboratory called CERN, were spectacular.
Public interest in science coverage is for the high-tech junkies and for those individuals interested in health-related breakthroughs. This is why science and health journalism usually go together. More recently, with climate change issues on the rise, environmental science is increasingly popular. |
|
Read more... [The consideration of good science journalism]
|
|
Media Releases
|
|
Written by Gavin Chait
|
|
Tuesday, 31 March 2009 00:00 |
|
In 1993, after four years of research, Napoleone Ferrara had a breakthrough while studying tumour-development in mice. He had discovered an inhibitor for tumour angiogenesis, the process by which cancer grows uncontrollably in the body. Gordon Ide had identified that new blood vessel development was essential to providing oxygen and nutrients for tumour growth back in the early 1900s. Ferrara was first find to a molecular inhibitor for vascular endothelial growth factor (VEGF), a main protein involved in inducing angiogenesis. Genentech, where Ferrara worked, immediately set about the lengthy process of clinical trials on a number of related cancers. Calamity struck in September 2002, when the drug, now called bevacizumab, failed to meet its primary efficacy endpoint of progression-free survival in a phase III breast cancer trial. In 2004, they finally hit success. A trial consisting of 925 patients diagnosed with previously untreated metastatic colon cancer indicated that patients on bevacizumab had a median end-point survival time of five months longer than those without. This was the best result ever seen in a Phase III trial for any drug. The FDA approved bevacizumab, now under the name of Avastin, for colorectal cancer treatment on 26 February 2004. |
|
Read more... [The betrayal of intellectual property and the incentive to produce]
|
|
Media Releases
|
|
Written by Dr Wilmot James
|
|
Thursday, 26 March 2009 05:25 |
 Unintended consequences Autumn is here. The angle of light fall is different. The quality appears sharper perhaps because there is more moisture in the air.
Nature smells differently this time of the year. The fragrance of Table Mountain is unmistakably that of autumn.The smell is the sum total of all of natural olfactory molecules pumped out this time of the year by the varieties of fynbos. Add the smell of the earth and of natural decay. The most striking to us is the wonderfully medicinal aroma of buchu. The normal seasonal changes in their biochemistries prompt the expression of greater or lesser smells.
There is a website that gives instructions about how to make a house smell like Autumn. Take orange peels, marigold flower heads, dried apples, cloves, cinnamon chips, allspice and orange essential oils, cook them, dry them and stuff the stuff into sachets. I think it is safe to say that we are talking here of the smell of Autumn in North America.
So, there is as usual normal natural variation in the smell of Autumn. They all though signal to the human body to prepare for the coming of winter. As for all other organisms that must modify their lifestyles seasonally, our bodies respond powerfully and viscerally to these natural cues even though we may not be aware of them. |
|
Read more... [As winter draws near, so does climate change]
|
|
Media Releases
|
|
Written by Gavin Chait
|
|
Monday, 16 March 2009 00:00 |
|
Neurodegenerative diseases are doubly traumatic. Seemingly healthy people can gradually lose control of their muscles, motor-skills and even their minds. Then, even if the source of the degeneration can be stopped, neurons regenerate extremely slowly, if at all. The bulk of neurons are formed during pre-natal development from stem cells. These are cells that have the potential to form a wide variety of different types of cells and are undifferentiated. Adults do have stem cells, but these are multipotent or oligopotent, meaning that they can only differentiate into a few types of cells. The adult brain even has a small pool of neural stem cells. However, the most useful stem cells are those found in embryos, particularly those in the morula phase of foetal development. These stem cells are totipotent and can form any cell at all. It is hoped that research in this area will unlock a way to repair degenerative ailments. As far as scientific advancement goes, this is all very encouraging. However, there is one very large problem. The only way that these embryonic stem cells can be harvested is by sacrificing a set of cells that have the potential to become a human being. |
|
Read more... [Obama revitalises the science, but leaves the politics of embryonic stem cell research undecided]
|
|
Media Releases
|
|
Written by Dr Wilmot James
|
|
Wednesday, 04 March 2009 15:00 |
 The smog of war Lets start with the bad news: climate change and global warming are already affecting our health and it will get worse. How much worse requires research and assessment and we have not undertaken a comprehensive study. Few middle income countries have but that is no excuse for doing nothing.
Most European have completed what is known as a climate change health impact assessment. Heatstroke related deaths caused by very hot European summers prompted them to take action. As temperatures will rise we must expect more deaths due to heatstroke worldwide.
The raging fires in California, Australia, the Cape (the Cape of Fire Storms!) and elsewhere have tragically highlighted the need to adjust human settlement patterns and prepare better for the devastation they bring.
How does climate change and global warming affect the health of human beings? The 2004 International Comparative Risk Assessment examined health risks and they estimated that 166,000 deaths in 2000. They also estimated that the lives of individuals were shortened by 5,5 million years because of climate change factors. |
|
Read more... [Preparing for Global Climate Change]
|
|
|